ST3GAL1 and ovarian carcinoma: Notably, high α2,3-sialyltransferase type I (ST3Gal I) expression is associated with advanced stage epithelial ovarian cancer and has been linked to ovarian cancer cell migration and peritoneal dissemination via an epidermal growth factor receptor-dependent mechanism (31).